MiNK Therapeutics(INKT) - 2024 Q3 - Earnings Call Transcript

MiNK Therapeutics, Inc. (NASDAQ:INKT) Q3 2024 Earnings Conference Call November 14, 2024 8:30 AM ET Company Participants Alexa Buffa - Corporate Communications Jennifer Buell - President and Chief Executive Officer Christine Klaskin - Principal Financial and Accounting Officer Paul Ibbett - Scientist Conference Call Participants Emily Bodnar - H.C. Wainwright Operator Thank you for standing by. I would like to welcome everyone to the MiNK Therapeutics Third Quarter 2024 Financial Results. I would now like t ...